Table 1 |
|
|
Outcome criteria in the PLATINO project. |
|
|
Outcome |
Definition* |
|
|
|
|
Spirometric criteria* |
|
|
FIXED RATIO |
Post-bronchodilator FEV1/FVC < 70% [10] |
|
GOLD |
Post-bronchodilator FEV1/FVC < 70 and FEV1 < 80% of predicted value [10] |
|
ATS |
Post-bronchodilator FEV1/FVC below the 5th percentile and FEV1 < 100% of predicted value [11] |
|
ERS |
Post-bronchodilator FEV1/FVC < 88% of the predicted value for men and < 89% for women [12] |
|
Symptom-based criteria |
|
|
Chronic bronchitis |
Cough with phlegm for at least 3 months a year in the last 2 years |
|
Asthma |
Wheezing within the last 12 months |
|
Emphysema |
Breathlessness due to exercise |
|
Medical diagnosis |
|
|
COPD |
Reported lifetime diagnosis of COPD |
|
Chronic bronchitis |
Reported lifetime diagnosis of chronic bronchitis |
|
Emphysema |
Reported lifetime diagnosis of emphysema |
|
Asthma |
Reported lifetime diagnosis of asthma |
|
|
|
|
FEV1 = forced expiratory volume in the first second; FVC = forced vital capacity For initial analyses of lung function measurements, the NHANES III Mexican American reference values were used [13]. |
|
|
Menezes et al. BMC Medical Research Methodology 2004 4:15 doi:10.1186/1471-2288-4-15 |
|